Compound Summary
Geranylgeranylacetone
Compound Information
Geranylgeranylacetone
Compound Name: | Geranylgeranylacetone |
Compound CID: | 5282199 |
Synonyms: | teprenone Geranylgeranylacetone Tetraprenylacetone Selbex 6809-52-5 More... |
Iupac Name: | (5E,9E,13E)-6,10,14,18-tetramethylnonadeca-5,9,13,17-tetraen-2-one |
InChI: | InChI=1S/C23H38O/c1-19(2)11-7-12-20(3)13-8-14-21(4)15-9-16-22(5)17-10-18-23(6)24/h11,13,15,17H,7-10,12,14,16,18H2,1-6H3/b20-13+,21-15+,22-17+ |
InChIKey: | HUCXKZBETONXFO-NJFMWZAGSA-N |
Canonical Smiles: | CC(=CCCC(=CCCC(=CCCC(=CCCC(=O)C)C)C)C)C |
Isomeric Smiles: | CC(=CCC/C(=C/CC/C(=C/CC/C(=C/CCC(=O)C)/C)/C)/C)C |
Molecular Weight: | 330.5 |
Molecular Formula: | C23H38O |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
Geranylgeranylacetone
Molecular Weight: | 330.5 |
Molecular Formula: | C23H38O |
Hydrogen Bond Donor Count: | 0 |
Hydrogen Bond Acceptor Count: | 1 |
Rotatable Bond Count: | 12 |
Heavy Atom Count: | 24 |
Complexity: | 482 |
Synonyms
Geranylgeranylacetone
| Geranylgeranylacetone | Geranylgeranylacetone |
|---|---|
teprenone |
Geranylgeranylacetone |
Tetraprenylacetone |
Selbex |
6809-52-5 |
3796-63-2 |
Teprenona |
Teprenonum |
Teprenonum INN-Latin |
Teprenona INN-Spanish |
UNII-S8S8451A4O |
(5E,9E,13E)-6,10,14,18-tetramethylnonadeca-5,9,13,17-tetraen-2-one |
57B67OXM8F |
6,10,14,18-tetramethylnonadeca-5,9,13,17-tetraen-2-one |
5,9,13,17-Nonadecatetraen-2-one, 6,10,14,18-tetramethyl-, (E,E,E)- |
E-0671 |
Geranylgeranyl acetone |
(5E,9E,13E)-6,10,14,18-Tetramethyl-5,9,13,17-nonadecatetren-2-one |
(5E,9E,13E)-Teprenone |
Teprenone INN:JAN |
CHEBI:31649 |
UNII-57B67OXM8F |
Selbelle |
5,9,13,17-NONADECATETRAEN-2-ONE, 6,10,14,18-TETRAMETHYL- |
CHEMBL79686 |
SCHEMBL157509 |
SCHEMBL157511 |
DTXSID901166719 |
S8S8451A4O |
Ea-0671 |
BCP11723 |
HY-B0779 |
ZINC1915509 |
MFCD00869547 |
s5006 |
AKOS015894922 |
(E,E,E)-GERANYLGERANYL ACETONE |
CCG-267813 |
CS-3560 |
E-671 |
809T525 |
SR-01000944917 |
Q-201789 |
Q7701388 |
SR-01000944917-1 |
(5E,9E,13E)-6,10,14,18-Tetramethyl-5,9,13,17-nonadecatetraen-2-one |
(9E,13E)-6,10,14,18-tetramethylnonadeca-5,9,13,17-tetraen-2-one |
5,9,13,17-NONADECATETRAEN-2-ONE, 6,10,14,18-TETRAMETHYL-, (5E,9E,13E)- |
Experimental Data
Geranylgeranylacetone
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mus musculus | 600.000000000000000 | ppm | 787.000000000000000 | 825.000000000000000 | 5.000000000000000 | 1047.000000000000000 | 1070.000000000000000 | 2.000000000000000 | NS | C57BL/6 J | MALES | 33788371 | Inactive |
| Mus musculus | 600.000000000000000 | ppm | 874.000000000000000 | 894.000000000000000 | 2.000000000000000 | 1047.000000000000000 | 1081.000000000000000 | 3.000000000000000 | NS | C57BL/6 J | FEMALES | 33788371 | Inactive |
Experimental Data Visualization
Geranylgeranylacetone
Statistics Data
Geranylgeranylacetone
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Mus musculus | 5.000000000000000 | 3.000000000000000 | 1 | 2 |
Statistics Data Visualization
Geranylgeranylacetone
